Kevin is a First Vice President and a member of CBRE’s National Life Sciences Practice Group. He specializes in assisting life sciences and biotech companies develop and achieve real estate strategies that account for the flexibility needed in a constantly changing industry. His in-depth knowledge of the biotech life cycle, including initial funding, drug development, clinical trials and capital events, allow him to tailor specific strategies to his clients' needs. His background working for an international life sciences developer/owner offers a unique perspective to leverage the best possible real estate outcome for clients.
Prior to joining CBRE, Kevin spent 12 years working for BioMed Realty/Blackstone, a leading provider of real estate to the life sciences industry. After 4 years in the Philadelphia region handling leasing, he moved to the DC area in 2010 to open BioMed’s Maryland office. There he spearheaded leasing, development and acquisition efforts for the Mid-Atlantic region, totaling 2.5 million square feet in inventory. He negotiated and completed over 2 million square feet of lease transactions and was involved in the acquisition of over 650,000 square feet across several buildings. Upon fully leasing up the Mid-Atlantic portfolio, he oversaw the disposition of 2 million square feet.